Washington DC, February 23: In a bid to strengthen its ties with India, US President Joe Biden's administration said it is looking forward to an "overarching" MoU to enhance health partnership with India. Talking about the MoU State Department Spokesperson Ned Price asserted that the cooperation between the two countries on COVID-19 builds on decades of successful collaboration in health and biomedical research.
Ned Price said, “We look forward to an overarching MoU to enhance health cooperation between our two countries (US and India). We are working together on developing diagnostics, therapeutics, vaccines to combat the disease (COVID-19) and to recognise the importance of manufacturing critical drugs during this time and making them accessible globally.”
He further praised India saying, India's pharmaceutical sector is strong and well-established and has long played a central role in manufacturing lifesaving vaccines for global use. "India's pharmaceutical sector is strong and well-established and has long played a central role in manufacturing life-saving vaccines for global use. We are pleased that the US pharmaceutical industry has been coordinating with Indian companies since the beginning of this pandemic,” Price said.
Price further added, “When it comes to the broad issue of coordination between the United States and India on COVID-19, I would say that cooperation between our two countries builds on decades of a successful partnership in health and biomedical research.”
Moreover, he added, "US is partnering with India to strengthen the global response to COVID-19 - ranging from addressing infectious disease outbreaks, strengthening health systems to securing global supply chains."
He said the US and India recently welcomed an initiative to collaborate through an International Center of Excellence in Research focused on infectious disease, including COVID-19 and other emerging threats.